Results 191 to 200 of about 56,049 (248)

Quality Over Quantity: Targeting Lipoprotein(a) Beyond Circulating Levels. [PDF]

JACC Basic Transl Sci
Tirandi A, Liberale L, Camici GG.
europepmc   +1 more source

BASTA trial: protocol for a randomised, double-blind, placebo-controlled, crossover trial investigating the effects of atorvastatin on bile acid diarrhoea. [PDF]

BMJ Open
Lynggaard MB, Olsen SS, Forman JL, Kårhus ML, Gluud LL, Lund AB, Ellegaard AM.   +6 more
europepmc   +1 more source

Atorvastatin Reduces Alcohol-Related Cardiac and Liver Tissue Damage, Oxidative Stress, Inflammation, Apoptosis, and Thiol-Disulfide Imbalance in Rats. [PDF]

J Biochem Mol Toxicol
Demirtas C, Kılıç Ş, Babaoğlu M, Asal S, Tenekeci EG, Beyaztaş H, Guler EM, Erguven SP, Sevgin K.   +8 more
europepmc   +1 more source

The Influence of Statin Therapy on Markers of Endothelial Dysfunction, Endocan and Endoglin, in Postmenopausal Women-A Prospective Study. [PDF]

Biomedicines
Šojat D, Pirić M, Lukić M, Horvat V, Šafer M, Feldi I, Bačun T, Kibel A.   +7 more
europepmc   +1 more source

Atorvastatin accelerates hematoma absorption and ameliorates cognitive impairment in patients with chronic subdural hematoma complicated by cognitive dysfunction: a retrospective analysis. [PDF]

Front Pharmacol
He S, Zhang L, Xue F, Zhang W, Xie F.
europepmc   +1 more source

Safety and Efficacy Assessment of Cannabis Plant Compared to Atorvastatin for Lipid Lowering in Diabetic and Obese Wistar Male Rats. [PDF]

Life (Basel)
Mărănducă MA, Clim A, Floria M, Tănase DM, Tamba B, Szilagyi A, Filipiuc LE, Gogu MR, Cozma CT, Șerban DN, Șerban IL.   +10 more
europepmc   +1 more source

Atorvastatin-Associated Severe Bradyarrhythmia Following Multiorgan Dysfunction: A Case Report. [PDF]

Clin Case Rep
Kou XQ, Wang YZ, Gan YR, Zhang YL, He SY, Zhang Z.   +5 more
europepmc   +1 more source

HLA and non-HLA genetic analyses reveal suggestive variants associated with statin-induced liver injury. [PDF]

Hepatol Commun
Zaborenko CJ, Schwantes-An TH, Li YJ, Dellinger A, Nicoletti P, Daly AK, Aithal G, Chalasani N, Drug-Induced Liver Injury Network.   +8 more
europepmc   +1 more source

Atorvastatin-associated neurological adverse events: a disproportionality analysis with adjustment for confounding by indication. [PDF]

Front Med (Lausanne)
He X, Zhou Q, Zhang M, Wang D, Xu X.
europepmc   +1 more source

Comparison of pharmacokinetics and safety of fixed-dose versus loose combination of atorvastatin/fenofibrate 10/145 mg in healthy Korean participants. [PDF]

Transl Clin Pharmacol
Jang H, Khwarg J, Huh KY, Park DM, Park H, Yu KS.   +5 more
europepmc   +1 more source